ATE356202T1 - Attenuierte stabile tollwutvirusmutante und lebende impfstoffe - Google Patents

Attenuierte stabile tollwutvirusmutante und lebende impfstoffe

Info

Publication number
ATE356202T1
ATE356202T1 AT99973064T AT99973064T ATE356202T1 AT E356202 T1 ATE356202 T1 AT E356202T1 AT 99973064 T AT99973064 T AT 99973064T AT 99973064 T AT99973064 T AT 99973064T AT E356202 T1 ATE356202 T1 AT E356202T1
Authority
AT
Austria
Prior art keywords
attenuated
stable
rabies virus
live vaccines
virus mutant
Prior art date
Application number
AT99973064T
Other languages
English (en)
Inventor
Teshome Mebatsion
Karl Klaus Conzelmann
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE356202T1 publication Critical patent/ATE356202T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99973064T 1998-11-27 1999-11-19 Attenuierte stabile tollwutvirusmutante und lebende impfstoffe ATE356202T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204001 1998-11-27

Publications (1)

Publication Number Publication Date
ATE356202T1 true ATE356202T1 (de) 2007-03-15

Family

ID=8234392

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99973064T ATE356202T1 (de) 1998-11-27 1999-11-19 Attenuierte stabile tollwutvirusmutante und lebende impfstoffe

Country Status (16)

Country Link
US (1) US6719981B1 (de)
EP (1) EP1131414B1 (de)
AR (1) AR021406A1 (de)
AT (1) ATE356202T1 (de)
AU (1) AU1386100A (de)
BR (1) BR9915703B1 (de)
CA (1) CA2352231C (de)
CY (1) CY1106570T1 (de)
DE (1) DE69935445T2 (de)
DK (1) DK1131414T3 (de)
ES (1) ES2283150T3 (de)
ID (1) ID28968A (de)
IL (2) IL143149A0 (de)
PT (1) PT1131414E (de)
TR (1) TR200101445T2 (de)
WO (1) WO2000032755A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2257505T3 (es) 2001-04-23 2006-08-01 Akzo Nobel N.V. Mutantes de virus de la rabia atenuados y vacunas vivas correspondientes.
EP1434862A4 (de) 2001-07-20 2005-04-06 Univ Georgia Res Found Attenuiertes tollwutvirus mit einer nukleoproteinmutation an der phosphorylierungsstelle zur impfung gegen tollwut und gentherapie im zns
AU2006304268B2 (en) * 2005-10-14 2011-09-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus vector systems and compositions and methods thereof
US7785874B2 (en) * 2007-01-11 2010-08-31 The Salk Institute For Biological Studies Compositions and methods for monosynaptic transport
TW200907058A (en) * 2007-05-30 2009-02-16 Wyeth Corp Raccoon poxvirus expressing rabies glycoproteins
ES2528472T3 (es) 2011-02-03 2015-02-10 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Vacunas multivalentes para el virus de la rabia y filovirus
CN103865889B (zh) * 2014-04-03 2015-02-25 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn鸡胚细胞适应株
EP4104854A3 (de) 2016-04-04 2023-03-08 The United States of America as represented by the Secretary of the Department of Health and Human Services Multivalente impfstoffe gegen tollwutvirus und coronaviren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent
FR2693655B1 (fr) * 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
SE0002498D0 (sv) 2000-07-03 2000-07-03 Stefan Schwartz Papillomavirus vaccine
US20050247051A1 (en) 2001-12-10 2005-11-10 Donaldson Company, Inc. Exhaust treatment control system for an internal combustion engine
DE102004009653A1 (de) 2004-02-27 2005-09-22 Cycos Ag Kommunikationsserver und Verfahren zum Aufbau und Betrieb einer Konferenz-Kommunikationsverbindung

Also Published As

Publication number Publication date
DE69935445D1 (de) 2007-04-19
ES2283150T3 (es) 2007-10-16
AR021406A1 (es) 2002-07-17
WO2000032755A1 (en) 2000-06-08
TR200101445T2 (tr) 2001-10-22
IL143149A0 (en) 2002-04-21
AU1386100A (en) 2000-06-19
EP1131414A1 (de) 2001-09-12
CA2352231C (en) 2010-06-01
CA2352231A1 (en) 2000-06-08
ID28968A (id) 2001-07-19
DK1131414T3 (da) 2007-06-18
BR9915703A (pt) 2001-08-14
IL143149A (en) 2007-12-03
EP1131414B1 (de) 2007-03-07
US6719981B1 (en) 2004-04-13
PT1131414E (pt) 2007-04-30
BR9915703B1 (pt) 2012-09-04
DE69935445T2 (de) 2007-11-29
CY1106570T1 (el) 2012-01-25

Similar Documents

Publication Publication Date Title
DE60135059D1 (de) Positionsabhängiges Chatsystem und Verfahren
ATE357252T1 (de) Adjuvanzsysteme und impfstoffe
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
GB2337755B (en) Virus vaccine
DE60126977D1 (de) Chirurgisches system mit griff und kanule
DE69723854D1 (de) Stabile glasartige pulverformulierungen
SG10201710373RA (en) Methods and compositions for treating hepatitis c virus
NL300233I1 (nl) Method of separating rotavirus variant and live attenuated rotavirus vaccine.
NO20006191D0 (no) Vaksine
NO20030239L (no) Modifisert virus
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
ATE356202T1 (de) Attenuierte stabile tollwutvirusmutante und lebende impfstoffe
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
DK1749885T3 (da) Infektiøs og svækket kvægdiarévirus
DE60208854D1 (de) Attenuierte rekombinante stabile Tollwutvirusmutanten und Lebendimpfstoffe
AU4529401A (en) Aids ancestral viruses and vaccines
DE69934108D1 (de) Kombinierte Impfstoffe gegen Hepatitis A und Hepatitis B
IS6184A (is) Bóluefni gegn ISA veiru
DE69835346D1 (de) Vakzine gegen infektiöse bursitis
DE69704008D1 (de) Lagerfähige, stabile und vernetzbare Siliconzusammensetzung
DK1105498T3 (da) HIV vaccine
ID28142A (id) Jenis virus penyebab hepatitis b vaksin dan penggunaannya
PT841943E (pt) Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas
IL149173A0 (en) Attenuated recombinant rabies virus mutants and live vaccines thereof
SE0000932D0 (sv) System och förfarande

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1131414

Country of ref document: EP